Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Lepu Biopharma Co. Ltd. Class H ( (HK:2157) ) is now available.
Lepu Biopharma Co. Ltd. has announced a placement agreement to issue up to 93,825,000 new H shares at a price of HK$5.02 per share, aiming to raise approximately HK$462.94 million. This strategic move is expected to enhance the company’s capital base and support its growth initiatives, although the completion of the placement is contingent upon certain conditions being met.
More about Lepu Biopharma Co. Ltd. Class H
Lepu Biopharma Co. Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the biopharmaceutical industry. The company focuses on developing and commercializing innovative therapies and products, with a market presence in Hong Kong.
Average Trading Volume: 20,275,659
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.24B
For an in-depth examination of 2157 stock, go to TipRanks’ Overview page.